Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
about
Lupus pathobiology based on genomics.Mechanisms of Autoantibody-Induced Pathology.Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.Fatal cardiac involvement complicating antisynthetase syndrome.The metastasis promoting protein S100A4 levels associate with disease activity rather than cancer development in patients with idiopathic inflammatory myopathies.Functional redundancy of MyD88-dependent signaling pathways in a murine model of histidyl-transfer RNA synthetase-induced myositis.Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1γ antibodies in adults with dermatomyositis.The clinical phenotypes of the juvenile idiopathic inflammatory myopathies.Autoantibodies to transcription intermediary factor TIF1β associated with dermatomyositis.Development of autoantibodies against muscle-specific FHL1 in severe inflammatory myopathies.Pure White Cell Aplasia and Necrotizing MyositisThe myositis autoantibody phenotypes of the juvenile idiopathic inflammatory myopathies.Latest advances in connective tissue disorders.Systematic protein-protein interaction and pathway analyses in the idiopathic inflammatory myopathies.Myositis registries and biorepositories: powerful tools to advance clinical, epidemiologic and pathogenic research.Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.Common pathways of autoimmune inflammatory myopathies and genetic neuromuscular disorders.T cells in myositis.Autoantibodies in polymyositis and dermatomyositis.Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.Immune mechanisms in polymyositis and dermatomyositis and potential targets for therapy.Innate immune-response mechanisms in dermatomyositis: an update on pathogenesis, diagnosis and treatment.Role of Jo-1 in the Immunopathogenesis of the Anti-synthetase Syndrome.Idiopathic inflammatory myopathies: from immunopathogenesis to new therapeutic targets.Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.Serological subsets of juvenile idiopathic inflammatory myopathies--an update.The utility of comprehensive autoantibody testing to differentiate connective tissue disease associated and idiopathic interstitial lung disease subgroup cases.[New aspects on the pathogenesis of myositis].A New Immunodot Assay for Multiplex Detection of Autoantibodies in a Cohort of Italian Patients With Idiopathic Inflammatory Myopathies.Anti-MDA-5 antibody-positive bullous dermatomyositis with palmar papules complicating rapidly progressive interstitial lung disease.Characteristics and predictors of malignancy in dermatomyositis: Analysis of 239 patients from northern China
P2860
Q33364409-1369D3CF-DD1C-46CE-89FC-4F915E69F9BDQ33740580-09920969-7D33-4833-8E85-6BDD975E83DDQ33814323-95F7634E-6DBC-47DA-94AF-93075AEF28FDQ34130694-577A4FE1-14D4-4F34-8113-63970D6AAAC0Q34560305-39414432-6196-4D9A-A459-2E2DEED34FD3Q35095086-9FBA0331-D137-4C77-851A-E9157941F989Q35153899-2AC3BD41-3EC5-4776-AC5A-23D53603B490Q36086954-C61E228F-72C2-484E-AFA4-069E2213FE5FQ36245820-3D77DBC1-4A33-46B2-999C-B3123A7F4B77Q36335887-E7C3D044-6AD5-45C0-A6C7-DC7EEB3CCFC7Q36747683-ED5D2E06-D8B8-4107-B604-BFB583F5AF22Q37040711-FEAF0EA2-6766-475E-B06D-3413716A823CQ37058776-FB14B026-5FA4-4FC9-AE44-4BA6C3215CAAQ37073571-7E040F31-5662-42D9-9222-CA4EBDCC0725Q37368405-29318B5C-56B3-442C-AF28-F2849E07F22CQ37674765-A6356F80-185D-460C-AA43-80F0163E09D3Q37956169-F14E4C8F-78AA-4349-A645-0AFC656CEC55Q38070033-4EFC0C2C-DD3A-4E19-865C-3A579215DC8FQ38099556-1082B811-25BE-4FEC-8807-DF1D90BFD19DQ38124282-52FECE6D-1245-49A9-B719-F657E45CF781Q38130904-2AD7F814-81C0-44FD-BF07-D022DA77E569Q38221095-FA8EC31C-2D41-4B54-9005-E5C013141CA3Q38554195-B1CE9590-716B-4D14-885E-7A14F7F9E7A4Q38589301-773C05E9-E2FC-46F5-AD12-E142A18F01B3Q38646384-1AE95329-90D8-449B-83D0-CB16549F8B73Q38664251-7957091A-F8AB-4A9E-B5DC-5118E63C4159Q39198820-038D4A1B-CE62-48A3-91FF-F20BB28F6B9FQ43978656-DF8F1A6C-A5E1-476D-ACC8-18E817273048Q53790402-C4CBFE3C-9432-4085-A8E4-6BAB7A92E216Q54351638-7221CAC5-C119-41D7-A386-08D6C701FF0EQ57788718-C57AE417-B584-4EF7-B729-F4FF570DAC42
P2860
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@ast
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@en
type
label
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@ast
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@en
prefLabel
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@ast
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@en
P2093
P2860
P921
P356
P1476
Novel autoantibodies and clinical phenotypes in adult and juvenile myositis.
@en
P2093
Harsha Gunawardena
Neil J McHugh
Zoe E Betteridge
P2860
P2888
P356
10.1186/AR3275
P577
2011-03-18T00:00:00Z
P5875
P6179
1000461478